Total Consolidated Revenuefor Q2FY25 was flat year-on-year (YoY) atRs 3,623 crore. Revenue from Operationswas up4% YoYatRs 3,590 crore,(Up 8% YoYafter adjusting Q2FY24 revenue for Branded Formulations, India business) Core EBITDAatRs 992 crore, representscore operating marginsof28%. Net R&...
On a full-year basis, Biocon Biologics crossed theUSD 1 billionannual revenue mark in FY24, with revenue atRs 8,824 crore, reflecting a58%year-on-year growth driven by the consolidation of the acquired business and robust growth in the core business across advanced and emerging markets. Core ...
India’s PLI schemes to boost revenue of 720 companies by USD 459 billion over next 5 years: Goldman Sachs – EQ India Waaree Plans ₹8,000 Crore Solar Manufacturing Hub in Nagpur – EQ India REC Limited Disburses ₹54,692 Crore in Q3 FY25; Renewable Energy Loans Surge by 58pc ...